Ellerston Capital Investor
Ellerston Capital specialises in equity strategies. Today, they have over $5.1 billion in funds under management (as at 28 February 2017) – including separately managed accounts (SMAs), wholesale funds and retail offerings for a range of financial advisers, institutions and individual investors.
As a dedicated investment manager, they aim to do one thing exceptionally well: grow and protect their clients’ wealth through investing. They are passionate about creating value for their clients by identifying outstanding stocks and designing portfolios that perform over the long term.
Technology:
Biomarker Discovery & Validation
Number Of Exists:
6
Funding Status:
private
Investor Type:
Hedge Funds
Industry:
BioPharma AI
Headquarters:
Sydney,New South Wales,Australia,Oceania
Employee Number:
101-250
Founded Date:
1999-01-01

